Actionable news
All posts from Actionable news
Actionable news in AMGN: Amgen Inc.,

Amgen (AMGN) Earnings Report: Q3 2015 Conference Call Transcript

The following Amgen (AMGN - Get Report) conference call took place on October 28, 2015, 05:00 PM ET. This is a transcript of that earnings call:

Company Participants

  • Arvind Sood; Amgen; VP of IR
  • Robert Bradway; Amgen; Chairman and CEO
  • David Meline; Amgen; CFO
  • Anthony Hooper; Amgen; Head of Global Commercial Operations
  • Sean Harper; Amgen; Head of R&D

Other Participants

  • Matt Roden; UBS; Analyst
  • Terence Flynn; Goldman Sachs; Analyst
  • Michael Yee; RBC Capital Markets; Analyst
  • Eric Schmidt; Cowen and Company; Analyst
  • Vikram Ashoka; Morgan Stanley; Analyst
  • Mark Schoenebaum; Evercore ISI; Analyst
  • Cory Kasimov; JPMorgan; Analyst
  • Ying Huang; BofA Merrill Lynch; Analyst
  • Eun Yang; Jefferies; Analyst
  • Geoff Meacham; Barclays Capital; Analyst
  • Colleen Hanley; Robert W. Baird; Analyst
  • Chris Raymond; Raymond James; Analyst

MANAGEMENT DISCUSSION SECTION Operator: I will be your conference facilitator today for Amgen's Third Quarter Earnings conference call.


(Operator Instructions) I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may begin. Arvind Sood (VP of IR): Thank you. Good afternoon, everybody. I'd like to welcome you to our conference call to review our operating performance for the third quarter. Based on our strong results in Q3 I think you'll agree that our business is performing well and we are on target to deliver against our long term objectives and commitment. I think what's really exciting for us...